{"version":"1.0","type":"link","title":"Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer: final analysis of the randomized RATIONALE-315 trial.","author_name":"Wang C 외","author_url":"https://prs-insight.online/author/Wang%20C","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/94941","thumbnail_width":1200,"thumbnail_height":630}